Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
for
Hemophilia A, Factor VIII (FVIII)
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 0+
Code: NCT07692217
Recruiting
New
Biomarker Targeted Stimulation for Epileptiform Events
for
Epilepsy
Location: Fort Worth TX, Rochester MN, Palo Alto CA, Seattle WA
Sponsor: Cadence Neuroscience
Sex: Male
Age: 7+
Code: NCT06424977
Recruiting
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Location: Fort Worth TX, Kyle TX, Mobile AL, Cincinnati OH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218341
Phase 4, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Fort Worth TX, Tyler TX, Shreveport LA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase 3, Recruiting
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
for
Systemic Lupus Erythematosus (SLE)
Location: Denton TX, Oklahoma City OK, Corpus Christi TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 16+
Code: NCT07175285
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Fort Worth TX, Austin TX, Tulsa OK, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for
Low Grade Serous Ovarian Cancer
Location: Fort Worth TX, Tyler TX, Austin TX, Oklahoma City OK,
Sponsor: Verastem, Inc.
Sex: Female
Age: 18+
Code: NCT06072781
Phase 3, Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
for
Systemic Sclerosis
Location: Frisco TX, Austin TX, New Orleans LA, Jackson TN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07497087
Phase 3, Recruiting
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
for
Myositis
Location: Frisco TX, Oklahoma City OK, Katy TX, Houston TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05895786
Phase 3, Recruiting
Clinical Data Registry of Amblyopia Patients on Luminopia Treatment
for
Amblyopia
Location: Fort Worth TX, Crestview FL, Indianapolis IN,
Sponsor: Luminopia
Sex: All
Age: 0+
Code: NCT06429280
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event